|
The investigation has determined that report higher than expected troponin es results obtained from a single patient sample using vitros troponin i es (tropi es) reagent lot 6070 on a vitros 5600 integrated system.The results were considered discordant when compared to a vitros hs troponin i (hstni) result and a non-vitros troponin result obtained from the same patient sample.The assignable cause of the non-reproducible higher than expected patient sample result could not be determined.Based on historical qc fluid results, a vitros tropi es lot 6070 performance issue is not a likely contributor to the event.However, the customer does not process a control fluid with a troponin i concentration at or below the url.Therefore, the performance of the vitros tropi es reagent lot 6011 at or below the url concentration of 0.034 ng/ml cannot be determined, and a reagent issue cannot be entirely ruled out as a contributing factor to the event.The customer did not perform a precision test; therefore, instrument performance at the time of the event could not be verified.However, there was no evidence indicating an instrument related issue.Pre-analytical sample processing could not be ruled out as a contributing factor as the customer was not following the sample collection device manufacturers recommended centrifugation protocol.Improper pre-analytical sample handling may have contributed to the event.It is possible that cellular debris resulting from inadequate sample preparation was present in the affected sample; however, this could not be confirmed.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros tropi es reagent lot 6070.
|